Barclays initiates SpaceX and Palantir at Overweight
Barclays initiated SpaceX and Palantir Technologies at Overweight, citing competitive advantages and projecting growth and profitability.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Barclays Initiates STRO Overweight
Barclays starts coverage of Sutro Biopharma with overweight rating, citing growth potential. This may impact biotech sector stocks.